Some patients with type 2 diabetes say they are having more difficulty getting reimbursed for drugs like Ozempic as U.S. insurers implement restrictions designed to deter <a href="/business/healthcare-pharmaceuticals/obesity-drug-wegovys-popularity-has-us-emp…